Dr. Emily Elizabeth Schulman, MD

Dr. Schulman practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Schulman's NPI, 1891158085, was assigned on April 4, 2016. Dr. Schulman graduated from University of Maryland School of Medicine in 2016. Dr. Schulman holds Maryland license D0090026.

Dr. Schulman's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Schulman's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Schulman is also affiliated with University of Maryland Medical Center Midtown Campus. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Dr. Schulman to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schulman practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Schulman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Schulman is licensed in Maryland.

CMS data shows 319 Medicare services from Dr. Schulman across 7 procedure codes in 2024, for 188 Medicare patients. Medicare paid $32,740 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 188 Medicare patients who saw Dr. Schulman in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schulman's median patient age at 73, with 55% women.

In 2024, Dr. Schulman wrote 647 Medicare Part D claims for 123 patients. 94% of them were for generic drugs. CMS names the drug for 465 of them, across 14 drugs with 11 or more claims each, at $40,530 in total drug cost. In 2023, CMS named 197 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schulman for performance year 2024, reported as part of a group. Dr. Schulman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schulman as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Schulman, published from 2011 to 2022. Dr. Schulman's most frequent co-authors are Neeja Vivek Desai, MD, Joseph Jankovic, MD and Laurie A. Robak, MD.

CMS Open Payments shows 95 general payments to Dr. Schulman from 21 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $562.

Dr. Schulman graduated from University of Maryland School of Medicine in 2016.